Your browser doesn't support javascript.
loading
Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study.
Harmatz, Paul; Muenzer, Joseph; Ezgü, Fatih; Dalén, Per; Huledal, Gunilla; Lindqvist, Daniel; Gelius, Stefan Svensson; Wikén, Margareta; Önnestam, Kristin; Bröijersén, Anders.
Afiliação
  • Harmatz P; UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA. Electronic address: pharmatz@mail.cho.org.
  • Muenzer J; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Ezgü F; Gazi University Hospital, Ankara, Turkey.
  • Dalén P; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Huledal G; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Lindqvist D; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Gelius SS; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Wikén M; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Önnestam K; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
  • Bröijersén A; Swedish Orphan Biovitrum AB, SE-112 76 Stockholm, Sweden.
Mol Genet Metab ; 136(4): 249-259, 2022 08.
Article em En | MEDLINE | ID: mdl-35835061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mucopolissacaridose III Tipo de estudo: Clinical_trials Limite: Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mucopolissacaridose III Tipo de estudo: Clinical_trials Limite: Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article